We support the streamlining of innovation by providing a comprehensive suite of R&D, TID, and drug development solutions, enabling virtual companies to access world-class expertise without the burden of fixed costs with rapid, targeted insights.
We serve as the critical connection point between innovative biotech companies and expert solutions, delivering seamless integration of services and specialized knowledge that accelerates scientific progress while optimizing resource allocation.
We enhance translational capabilities by combining deep industry and academic knowledge into a single trusted source to transform scientific innovation into realistic possibilities.
Immunology
Oncology
Neurology
Autoimmunity
Infectious Disease
Vaccinology
Metabolic Disorderes
Target Identification
Target Validation
Assay Development Screens
CRO Commissioning and Management
Preclinical Testing/GLP-Tox
Biomarkers
Small Molecules
Biologics/New Biological Entities
Cell Therapy
Gene Therapy
Live Biotherapeutics
ASOs
Molecular Glues
Scientific Writing
Grant/Proposal Writing and Review
Training Materials/SOPs
Laboratory Capacity Development/Management
Research Infrastructure
Scientific Evaluation
Independent Analysis
Informed Decisions
Competitive Positioning
Innovation
Vision
Market Opportunities
Landscape Analysis
Challenges/Risks
Agility
Navigating the complexities of drug development requires deep scientific understanding across multiple therapeutic areas.
Our team of experienced scientists brings comprehensive expertise across seven critical therapeutic areas: Immunology, Oncology, Neurology, Autoimmunity, Infectious Disease, Vaccinology, and Metabolic Disorders. This breadth of knowledge enables us to address diverse challenges with specialized insights, whether developing novel cancer therapies or tackling complex neurological conditions. We leverage our cross-disciplinary approach to accelerate your programs through development bottlenecks, providing targeted solutions that reflect both scientific rigor and commercial awareness. Our therapeutic area specialists work collaboratively with clients to transform scientific potential into clinical reality.
Scientific expertise in drug discovery is key.
Our consultants provide comprehensive support from Target Identification and Validation through to Preclinical Testing and GLP-Tox studies. We excel in developing robust experimental design ranging from basic Assay Development from screening to the identification of promising targets and candidates. Our expertise extends to Biomarker discovery and validation, enabling more predictive translational outcomes from early preclinical stage to GLPTox. We also offer specialized CRO commissioning and management services, ensuring your external partnerships deliver maximum value within your timeline. By integrating these scientific capabilities, we help streamline your discovery pipeline, reducing development time while maintaining rigorous quality standards.
The evolving landscape of therapeutic development demands expertise across multiple drug modalities.
Our consultants offer specialised guidance across a comprehensive portfolio that includes Small Molecules, Biologics/New Biological Entities, and emerging platforms such as CAR-T cells and Gene Therapy. We provide tailored strategic direction for innovative approaches including Live Biotherapeutics, Antisense Oligonucleotides (ASOs), and Molecular Glues. Our scientific team understands the unique development challenges and regulatory considerations specific to each modality, enabling us to guide your programs through critical decision points with confidence.
Effective drug development programs require excellence in documentation, processes, and operational infrastructure.
Our consultants deliver premium Scientific Writing services that transform complex data into compelling narratives for publications, regulatory submissions, and stakeholder communications. We specialize in Grant/Proposal Writing and Review, enhancing funding success through strategic positioning and technical rigor. Our team creates comprehensive Training Materials and SOPs that ensure operational consistency and regulatory compliance. Additionally, our expertise in Laboratory Capacity Development and Management optimizes Research Infrastructure, workflow efficiency, and quality standards to accelerate your programs while maintaining scientific excellence.
Investment decisions in biotech and pharmaceutical assets require thorough scientific evaluation to identify both potential and risk.
Our consultants provides comprehensive VC/Asset due diligence services delivered by industry experts who understand both the science and market landscape. We conduct rigorous assessment of technological foundations, data quality, competitive positioning, and development strategy. Our independent analysis helps investors and strategic partners make informed decisions by evaluating scientific validity, identifying development challenges, and assessing commercial potential. We deliver clear, actionable insights that highlight both opportunities and risks across diverse therapeutic areas and modalities.
Transforming scientific innovation into a successful drug to treat patients requires more than technical excellence, it demands strategic vision.
Our scientific strategy consultancy provides the critical framework to align your discovery and development programs with Market Opportunities and business objectives. We help navigate complex decision pathways, from candidate selection to clinical trial design, ensuring resources target the most promising avenues. Our strategic approach integrates scientific rigor with commercial insights, regulatory landscape assessment, and competitive intelligence. By identifying potential challenges early and creating adaptable roadmaps, we help mitigate risks while accelerating development timelines thus making your organisation agile. Partner with us to transform promising science into strategic advantage in today’s competitive therapeutic landscape
